European bronchitis treatment market is projected to grow at a significant CAGR of around 3.5% during the forecast period (2020-2026). The market for bronchitis treatment in European region is expected to project a modest growth during the forecast period, backed by the rising prevalence of lung related diseases in the Western European nations, such as UK. As per the European Lung Foundation, around 16.5 million cases of acute bronchitis are registered every year in the region. Moreover, the bronchiolitis is one of the most common causes of hospital admissions in the first 12 months of children, leading to the growth of the bronchitis treatment market among children in the country.
Browse the full report description European Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/europe-bronchitis-treatment-market
The well-developed infrastructure of Europe has attracted the attention of global market players to expand their presence in the region, which in turn, is offering growth to the market. Moreover, European Lung Foundation is engaged in several research projects, funded by the European Union (EU). For instance, FRESH AIR is an EU Horizon 2020 project that has a goal of improving the health of individuals that are at risk or are currently dealing with chronic lung conditions in European countries that have limited resources of treatment, such as Vietnam, Uganda, Greece, and Kyrgyz Republic. These projects are expected to offer growth to the bronchitis treatment market in the region during the forecast period.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2019-2026 |
|
Base year |
2019 |
|
Forecast period |
2020-2026 |
|
Segments Covered |
By Technology |
|
Countries Covered |
UK, Germany, France, Italy, Spain, and Rest of Europe |
|
Key Companies Profiled |
Abbott Laboratories, Bayer AG, GlaxoSmithKline
PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected region/segment
o Recommendations
European Bronchitis Treatment Market – Segmentation
By Technology
o Antibiotics
o Anti-inflammatory drugs
o Bronchodilators
o Others (Mucolytics)
European Bronchitis Treatment Market – Segmentation by Geography
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/europe-bronchitis-treatment-market